,47 There is no doubt that the detailed mechanisms indicated to HBx, SUMOylated by RANBP2, related to the increase in HER2 offer opportunities for the development of targeted therapies aimed at mitigating the aggressive nature of HCC. The gene discussed is RANBP2; the disease is hepatocellular carcinoma.